Report cards › Companies › McKesson Corporation
McKesson Corporation: Prison and detention contracts records
Prison and detention contracts: 2560 records from the Department of Justice, from 2025 to 2026; the amounts total $299,129,704.
Newest first; records 1 to 50 of 2560. Each links to the agency's own record. Back to the report card.
| Date | Agency | What the agency recorded | Amount or outcome | Record | Retrieved | Matched | Report |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | Department of Justice | USAspending: $250,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61727F00000010 (1 action); latest action described as ""EO 14398" FCC LOMPOC FY27 B1 MCKESSON REGULAR" | $250,000 · $250,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $11,483.31 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B50726F00000079 (1 action); latest action described as "FOUR POINTS TECHNOLOGY (PYXIS LEASE & MAINTENANCE)" | $11,483 · $11,483.31 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $245,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B41427F00000011 (1 action); latest action described as "FY27 B1 MCKESSON B12701813F PSYCH OCT 26" | $245,000 · $245,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $295,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B41427F00000010 (1 action); latest action described as "FY27 B1 MCKESSON B12701913F MEDS OCT 26" | $295,000 · $295,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $7,382.93 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B21726F00000006 (1 action); latest action described as "INMATE MEDICATION FY26 EO 14398 INCLUDED" | $7,383 · $7,382.93 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $18,467.28 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B21127F00000009 (1 action); latest action described as "MAT MEDICATION FUNDING FY27" | $18,467 · $18,467.28 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $349.09 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20727P00000023 (1 action); latest action described as "MCKESSON OPEN MARKET" | $349 · $349.09 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $416.82 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20727P00000022 (1 action); latest action described as "MCKESSON OPEN MARKET MEDICATIONS" | $417 · $416.82 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $500,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20127F00000020 (1 action); latest action described as "1ST QUARTER REGULAR DRUGS COVERING 10/01/2026 THROUGH 12/31/2026 DELIVERY DATES FROM 10/01/2026 THROUGH 12/31/2026 DRUG AND PHARMACEUTICAL ORDER. *SECURITY HAZARD: DELIVER TO HEALTH SERVICES STAFF ONLY*" | $500,000 · $500,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 23, 2026 | Department of Justice | USAspending: $19,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20127F00000019 (1 action); latest action described as "1ST QUARTER FSA CONTROLLED DRUGS COVERING 10/01/2026 THROUGH 12/31/2026 DELIVERY DATES FROM 10/01/2026 THROUGH 12/31/2026 DRUG AND PHARMACEUTICAL ORDER. *SECURITY HAZARD: DELIVER TO HEALTH SERVICES STAFF ONLY*" | $19,000 · $19,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $244,200.09 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61527F00000006 (1 action); latest action described as ""EO 14398" FCC TUCSON FY27 MCKESSON-AIC PHARMACEUTICALS" | $244,200 · $244,200.09 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $9,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B51627F00000005 (1 action); latest action described as "FCI THREE RIVERS REGULAR INMATE MEDICATION FY27" | $9,000 · $9,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $3,079.34 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B51127F00000008 (1 action); latest action described as "FY26 (B1) MCKESSON MAT FUNDING" | $3,079 · $3,079.34 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $5,919.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B41227F00000010 (1 action); latest action described as "FY27 B1 FSA MCKESSON FSA MOUD MEDS ANNUAL OCT 26 PR 0015" | $5,919 · $5,919.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $10,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B41227F00000009 (1 action); latest action described as "FY27 B1 MCKESSON BT OPEN MARKET OCT 26" | $10,000 · $10,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $5,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B41227F00000007 (1 action); latest action described as "FY27 B1 MCKESSON BT OPEN MARKET CONTROLLED OCT 26" | $5,000 · $5,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $160,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B40627F00000012 (1 action); latest action described as "FY27 B1 MCKESSON CONTRACT MEDS OCT 26" | $160,000 · $160,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $14,502.77 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B31727F00000007 (1 action); latest action described as "GENERAL MEDICATION ORDER" | $14,503 · $14,502.77 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $90,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20827F00000022 (1 action); latest action described as "MEDICATIONS FOR FCI LORETTO FOR NOVEMBER FY 27" | $90,000 · $90,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $90,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20827F00000021 (1 action); latest action described as "MEDICATIONS FOR FCI LORETTO OCT FY27" | $90,000 · $90,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $2,000,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20527F00000022 (1 action); latest action described as "FY27 INTERAGENCY AGREEMENT PHARMACEUTICALS FOR FMC DEVENS." | $2,000,000 · $2,000,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $2,500.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20127F00000011 (1 action); latest action described as "1ST QUARTER CONTROLLED DRUGS COVERING 10/01/2026 THROUGH 12/31/2026 DELIVERY DATES FROM 10/01/2026 THROUGH 12/31/2026 DRUG AND PHARMACEUTICAL ORDER. *SECURITY HAZARD: DELIVER TO HEALTH SERVICES STAFF ONLY*" | $2,500 · $2,500.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $100,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B10727F00000011 (1 action); latest action described as "MCKESSON PHARMACEUTICALS NOVEMBER 26 FY27 36W79720D0001" | $100,000 · $100,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $12,286.33 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B10727F00000005 (2 actions); latest action described as "MCKESSON MAT OCTOBER 26 FY27 36W79720D0001 MOD TO INCREASE FOR ACCRUAL" | $12,286 · $12,286.33 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $145,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B10727F00000002 (2 actions); latest action described as "MCKESSON PHARMACEUTICALS OCTOBER 26 FY27 36W79720D0001 MOD TO INCREASE FOR ACCRUAL" | $145,000 · $145,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 22, 2026 | Department of Justice | USAspending: $168,460.10 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B10227F00000001 (2 actions); latest action described as "FY27 B1 MCKESSON MEDICATIONS OCT 26" | $168,460 · $168,460.10 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $10,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61926F00000151 (1 action); latest action described as "PHARMACY PURCHASES (REGULAR)OCTOBER THRU DECEMBER FY2027, QTR1 INTERAGENCY AGREEMENT (IAA) 943 EO 14398" | $10,000 · $10,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $2,500.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61926F00000150 (1 action); latest action described as "PHARMACY PURCHASES (NARCOTIC) OCTOBER THRU DECEMBER 2026, FY 27 QTR 1 INTERAGENCY AGREEMENT (IAA) 943 EO 14398" | $2,500 · $2,500.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $25,647.98 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61926F00000149 (1 action); latest action described as "PHARMACY PURCHASES (MAT)JULY 1-SEPTEMBER 30, 2026 QTR4 INTERAGENCY AGREEMENT (IAA) 943 EO 14398" | $25,648 · $25,647.98 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $20,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61027F00000011 (1 action); latest action described as "MCKESSON CONTRACT - SUPPLY OF PHARMACEUTICALS - NOV FY 27 "EO 14398"" | $20,000 · $20,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $20,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61027F00000010 (1 action); latest action described as "MCKESSON CONTRACT - SUPPLY OF PHARMACEUTICALS - OCT FY 27 "EO 14398"" | $20,000 · $20,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $500.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61027F00000009 (1 action); latest action described as "MCKESSON CONTRACT SUPPLY OF CONTROLLED PHARMACEUTICALS. "EO 14398"" | $500 · $500.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $500.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61027F00000008 (1 action); latest action described as "MCKESSON CONTRACT SUPPLY OF PHARMACEUTICALS. "EO 14398"" | $500 · $500.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $14,293.42 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B61027F00000006 (1 action); latest action described as "MCKESSON MAT MEDS FY 27 "EO 14398"" | $14,293 · $14,293.42 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $250,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B51927F00000020 (1 action); latest action described as "OCTOBER MONTHLY MEDICATIONS" | $250,000 · $250,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $315,879.48 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B51527F00000009 (1 action); latest action described as "MCKESSON NON-CONTRACT MEDICATION 10/1/2026 THROUGH 9/30/2027. ACCOUNT NUMBER: 321045" | $315,879 · $315,879.48 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $1,564.01 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B51527F00000008 (1 action); latest action described as "MCKESSON NON-CONTRACT MEDICATION 10/1/2026 THROUGH 9/30/2027. ACCOUNT NUMBER: 321045" | $1,564 · $1,564.01 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $450,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B50827F00000013 (1 action); latest action described as "REFERENCE CONTRACT #36W79720D0001, MCKESSON CORP. FOR INMATE PHARMACEUTICALS FOR A SERVICE PERIOD OF OCTOBER 1, 2026-DECEMBER 11, 2026." | $450,000 · $450,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $32,960.98 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B50827F00000008 (1 action); latest action described as "REFERENCE CONTRACT #36W79720D0001, MCKESSON CORP. FOR INMATE MAT PROGRAM FOR INMATE PHARMACEUTICALS FOR A SERVICE PERIOD OF OCT 1, 2026-DEC 31, 2026" | $32,961 · $32,960.98 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $123,885.22 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B50427F00000009 (2 actions); latest action described as "MCKESSON - MEDICINE FOR INMATE POPULATION AT FPC BRYAN FY27 1ST QUARTER" | $123,885 · $123,885.22 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $5,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B41227F00000005 (1 action); latest action described as "FY27 B1 MCKESSON LD - CONTROLLED OCT 26" | $5,000 · $5,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $375,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B41227F00000004 (1 action); latest action described as "FY27 B1 MCKESSON LD - PRIME VENDOR OCT 26" | $375,000 · $375,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $117,223.01 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B30927F00000001 (1 action); latest action described as "MCKESSON REGULAR MEDICATIONS OCTOBER FY27" | $117,223 · $117,223.01 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $75,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B30127F00000002 (1 action); latest action described as "FY27 B1 OCT MCKESSON GENERAL/CONTROLLED MEDS" | $75,000 · $75,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $1,600.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20927F00000006 (1 action); latest action described as "INMATE MEDICATIONS-CLEAN-FY27" | $1,600 · $1,600.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $10,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20327P00000046 (1 action); latest action described as "MCKESSON PHARMACEUTICALS FOR INMATES" | $10,000 · $10,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $150,000.00 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B20327F00000013 (1 action); latest action described as "PRIME VENDOR PHARMACEUTICAL FOR DANBURY INMATE POPULATION IN ACCORDANCE WITH EO 14398 PROHIBITS FEDERAL CONTRACTORS AND SUBCONTRACTORS FROM ENGAGING IN RACIALLY DISCRIMINATORY DEI ACTIVITIES." | $150,000 · $150,000.00 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $350,802.75 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B12027F00000003 (1 action); latest action described as "FY27 MCKESSON REGULAR MEDICATION" | $350,803 · $350,802.75 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $12,745.58 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B11027F00000008 (1 action); latest action described as "FCI MANCHESTER MCKESSON (MAT FUNDING) FY27 1ST QTR" | $12,746 · $12,745.58 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
| Oct 21, 2026 | Department of Justice | USAspending: $19,336.50 obligated in fiscal year 2027 by Federal Prison System / Bureau of Prisons to MCKESSON CORPORATION under award 15B10927F00000015 (1 action); latest action described as "MCKESSON CONTRACT - ACCT 677508 - CONTROLLED AND NON-CONTROLLED MEDICATION PURCHASE FOR INMATE USE FOR OPIOID USE DISORDER TREATMENT (MAT THERAPY) - 90F MEDICATIONS/ 1060ADB -- MULTIPLE INVOICES PURCHASED FOR FY27 01-30 NOV" | $19,337 · $19,336.50 obligated (FY2027) | Source record | Oct 27, 2026 | matched by the parent company the agency reports | Report an error |
CSWH is not affiliated with these agencies.